A detailed history of Excalibur Management Corp transactions in Danaher Corp stock. As of the latest transaction made, Excalibur Management Corp holds 1,987 shares of DHR stock, worth $544,159. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,987
Previous 2,047 2.93%
Holding current value
$544,159
Previous $511,000 2.94%
% of portfolio
0.2%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$235.51 - $267.98 $14,130 - $16,078
-60 Reduced 2.93%
1,987 $496,000
Q1 2024

May 13, 2024

BUY
$224.58 - $256.19 $42,221 - $48,163
188 Added 10.11%
2,047 $511,000
Q4 2023

Feb 12, 2024

BUY
$185.1 - $233.13 $29,801 - $37,533
161 Added 9.48%
1,859 $430,000
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $2,796 - $3,187
12 Added 0.71%
1,698 $421,000
Q2 2023

Aug 08, 2023

SELL
$224.99 - $256.14 $16,424 - $18,698
-73 Reduced 4.15%
1,686 $404,000
Q4 2022

Feb 10, 2023

SELL
$241.42 - $282.29 $22,452 - $26,252
-93 Reduced 5.02%
1,759 $466,000
Q3 2022

Nov 04, 2022

SELL
$247.06 - $1507.4 $2,470 - $15,074
-10 Reduced 0.54%
1,852 $478,000
Q2 2022

Jul 25, 2022

SELL
$237.11 - $299.66 $7,113 - $8,989
-30 Reduced 1.59%
1,862 $472,000
Q1 2022

May 03, 2022

SELL
$257.27 - $315.76 $257 - $315
-1 Reduced 0.05%
1,892 $555,000
Q4 2021

Feb 10, 2022

SELL
$292.08 - $329.01 $57,831 - $65,143
-198 Reduced 9.47%
1,893 $623,000
Q2 2021

Jul 26, 2021

BUY
$225.08 - $271.69 $3,151 - $3,803
14 Added 0.67%
2,091 $561,000
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $772 - $1,060
-6 Reduced 0.29%
2,077 $367,000
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $10,560 - $14,707
-87 Reduced 4.01%
2,083 $288,000
Q4 2019

Feb 04, 2020

BUY
$133.47 - $153.48 $289,629 - $333,051
2,170 New
2,170 $333,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $199B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Excalibur Management Corp Portfolio

Follow Excalibur Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.